Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
As an investor I always find looking at the companies investors page a useful place to visit
https://www.synairgen.com/investors
Might be worth reading page 4 Sept 2023 clinical update
https://synairgen.ams3.digitaloceanspaces.com/230921-Synairgen-Interims_FINAL.pdf
Have been traded today !
When the traders here can generate 20% of the shares traded in a drop. I’ll start to worry. Until then I’m just sitting patiently waiting for the trials to start along with TFG
Why on earth would anyone pay attention to someone who told us the company was worth 2bn in a Spac. Then 600m if we put the for sale sign up and then dropped it to 200m
The guy is a trader out to create mischief
All that is happening at the moment is traders placing orders at lower values and MM trying to create some volume. The amounts are tiny and signify nothing.
It will continue until the trials start or we get news and it’s exactly what you could have expected and what I anticipated would happen when I posted at Xmas.
It’s exactly what traders on this board are playing on with their posts.
I guess it would be a sign of shareholder confidence if 100m or 40m or even 10m shares were being traded down.
At 0.25% of available shares being traded it’s a sign of nothing other than no news.
A great video for this boards posters
https://youtu.be/_Tr9Ncoo-yw
Are they screwing us over in the background?
I have no idea.
Even if they were can I do anything about it, other than vote against a proposal?
NO I can’t, so what’s the point in worrying about some imaginary scenario?
There is none
If I spend every other day on this board moaning about the CEO or the lack of updates, will I get one?
No
Does anyone other than a few posters who say the same thing daily imagine the board are hiding some vital news?
No because that just silly.
Trials take time. Investors have to be patient. It’s a pain.
But not as big a pain as the endless moaning on this board.
I’m just patiently waiting for the substantive update we will get before the trial starts.
Can’t say I’m in a hurry as the timeframe is very wide and we’re only 37 days into the window we were quoted.
I’m not expecting news for a while yet, If it drops sooner that’s a bonus. I’m reassured that they are taking the time to get this right.
More likely she wanted the CFO role thought she owned it when Ward stepped off the plate. Found she wasn’t guaranteed the role and has left.
Good news we’ve replaced a SVP of finance with a cheaper bean counter.
I guess the placing isn’t needed as the wage bill has just shrunk
Interim statement
“The Company’s cash resources are sufficient to cover its plans to design and
establish data from an observational study and two investigator-led/Synairgen-
sponsored Phase 2 clinical trials, including manufacture of active and placebo
for use in these trials”
Link to the drive page
https://drive.hhs.gov/host_tx.html
Very Synergistic language. If Casanova are looking to test their assay and J&J are looking for partnerships then both can see an interest from Barda if they can find an antiviral that’s virus agnostic and uses patient stratification.
Also of interest given Synairgens approach and covered in the Drive program Host Directed Therapies is the last paragraph on Patient stratification.
Our current areas of HDT focus include:
Interventions to prevent or reduce infection progression to severe outcomes
Therapies that improve long term outcomes and prevent health deterioration
Patient stratification to subtype populations for improved clinical management